Envigo's Podcast: Recent Episodes
Envigo RMS, LLC
Envigo provides essential products and research services for pharmaceutical, crop protection, and chemical companies as well as universities, governments, and other research organizations. Our company is founded on the principle that research partnerships depend on unmatched expertise, unwavering dedication to customer service and shared goals, Envigo is committed to helping customers realize the full potential of their products and research which contribute to enhancing the lives of people and animals as well as protecting the environment.
In our latest podcast, experts Dr. Jamie Naden and Sheryl Wildt explore ten steps for selecting the optimal oncology model, as well as how to validate a strain for oncology studies.
Dr. Kirsty Harper presented this session at SOT 2018 in San Antonio, Texas.
Checkpoint inhibitors release the immune system’s biological control mechanisms, increasing anti-tumor activity. As these products enter the clinic, increasingly in combination with other drugs, it is essential to understand potential risks. Design of appropriate non-clinical studies, interpretation of results and translation to the clinic is critical to understanding potential impact.
We are all aware that the UK is set to leave the EU on March 30 2019. BREXIT is a priority for Envigo and we are taking a leading role in Industry bodies to support the aspirations of the REACH regulation post BREXIT. During this episode Naheed Rehman discusses: What does leaving the EU mean for the UK chemical industry? What does this mean for Envigo? How is Envigo preparing for BREXIT; and BREXIT and EU chemical trade.